Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426

Ching-Fu Weng; Chi-Jung Huang; Shih-Hung Huang; Mei-Hsuan Wu; Ailun Heather Tseng; Yung-Chuan Sung; Henry Hsin-Chung Lee; Thai-Yen Ling

doi:10.3390/cancers13164024

,

and

¹

Division of Pulmonary Medicine, Department of Internal Medicine, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan

²

Department and Graduate Institute of Pharmacology, National Taiwan University, Taipei 100, Taiwan

³

Medical Research Center, Cathay General Hospital, Taipei 106, Taiwan

⁴

Department of Biochemistry, National Defense Medical Center, Taipei 114, Taiwan

Cancers2021, 13(16), 4024;https://doi.org/10.3390/cancers13164024

This article belongs to the Section Cancer Pathophysiology

Version Notes

Order Reprints

The authors would like to make a correction to their published paper [1].

There was a mistake in the original version of the article in Figures 1 and 2. We found that Figures 1 and 2 were misplaced in the article.

They should be replaced with the following Figure 1 and Figure 2:

Figure 1. Selection criteria for the subjects.

Figure 2. Histological patterns of lung adenocarcinoma. Representative hematoxylin and eosin-stained biopsy specimens: (A) lepidic-predominant pattern; (B) acinar-predominant pattern; (C) papillary-predominant pattern; (D) solid-predominant pattern; and (E) micropapillary-predominant pattern.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

Weng, C.-F.; Huang, C.-J.; Huang, S.-H.; Wu, M.-H.; Tseng, A.H.; Sung, Y.-C.; Lee, H.H.-C.; Ling, T.-Y. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426. [Google Scholar] [CrossRef] [PubMed]

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Correction: Weng et al. New International Association for the Study of Lung Cancer (IASLC) Pathology Committee Grading System for the Prognostic Outcome of Advanced Lung Adenocarcinoma. Cancers 2020, 12, 3426

Funding

Conflicts of Interest

Reference

Article Metrics

Citations

Article Access Statistics